Acorn Financial Advisory Services Inc. ADV Invests $93,000 in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Acorn Financial Advisory Services Inc. ADV acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 3rd quarter, HoldingsChannel reports. The firm acquired 10,338 shares of the pharmacy operator’s stock, valued at approximately $93,000.

Several other institutional investors have also bought and sold shares of WBA. New Covenant Trust Company N.A. purchased a new stake in shares of Walgreens Boots Alliance during the first quarter worth $35,000. Iron Horse Wealth Management LLC grew its stake in shares of Walgreens Boots Alliance by 162.5% during the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 1,300 shares during the last quarter. Blue Trust Inc. grew its stake in shares of Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 1,081 shares during the last quarter. Continuum Advisory LLC boosted its holdings in shares of Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 1,020 shares during the period. Finally, Strategic Investment Solutions Inc. IL purchased a new stake in shares of Walgreens Boots Alliance during the second quarter worth about $34,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $9.07 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. Walgreens Boots Alliance, Inc. has a 12-month low of $8.22 and a 12-month high of $27.05. The business’s 50 day moving average is $9.18 and its 200 day moving average is $12.21.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The business had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company’s revenue was up 5.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.67 EPS. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.03%. The ex-dividend date is Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -9.99%.

Analysts Set New Price Targets

WBA has been the subject of several research analyst reports. JPMorgan Chase & Co. lowered their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. Morgan Stanley decreased their target price on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research note on Friday, October 11th. UBS Group raised their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Jefferies Financial Group reduced their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. Finally, Barclays lifted their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average price target of $12.88.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.